{
  "ptid_time": "053_S_5202_2013-06-07",
  "img_path": "/data/qiuhui/data/adni/images/053_S_5202/2013-06-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,210 mm³, 62.1% above the reference mean. With a Z-score of 1.55 (94.0th percentile), this represents moderate enlargement; whole brain volume measures 1,117,550 mm³, 8.6% above the reference mean. With a Z-score of 1.07 (85.8th percentile), this represents mild enlargement; entorhinal cortex volume measures 4,587 mm³, 17.8% above the reference mean. With a Z-score of 1.38 (91.6th percentile), this represents mild enlargement; fusiform gyrus volume measures 20,372 mm³, 11.9% above the reference mean. With a Z-score of 1.34 (90.9th percentile), this represents mild enlargement; middle temporal gyrus volume measures 24,968 mm³, 21.7% above the reference mean. With a Z-score of 1.93 (97.3th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 65.7 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Smoking; Malignancy; Major Surgical Procedures. MMSE: 30.0. MoCA: 25.0. Logical Memory: 15.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.41 SUVR (significant elevated); Amyloid beta: 545.30 pg/mL (mild reduced); Total tau: 214.30 pg/mL (normal ); Phosphorylated tau: 21.40 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate ventricular enlargement (suggesting possible atrophy) and mild-to-moderate enlargement in key AD-related regions (entorhinal cortex, fusiform gyrus, middle temporal gyrus), which could indicate early neurodegeneration. However, cognitive scores (MMSE 30, MoCA 25) are largely intact, and biomarkers show only mildly reduced Aβ with elevated AV45 (suggesting amyloid deposition), but normal tau.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early neurodegenerative changes but preserved cognition).  \n**Confidence:** **Medium** (imaging suggests early AD pathology, but cognitive performance is borderline normal; longitudinal follow-up would help clarify progression).",
  "timestamp": "2025-07-26T08:01:31.955542"
}